Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Daneshmand Pharmaceutical, also known as Daneshmand Darou, is an Iranian pharmaceutical company specializing in the production and distribution of pharmaceutical raw materials, finished dosage forms, and nutritional supplements. Founded in 1995, the company serves as a critical supplier of active pharmaceutical ingredients (APIs) and excipients to the domestic healthcare industry. Their product portfolio spans several therapeutic areas, including cardiovascular health, gastroenterology, and analgesics. Daneshmand Pharmaceutical operates with a focus on international quality standards and maintains strategic partnerships to facilitate the import of high-quality medical components. The company plays a significant role in the regional supply chain, supporting both industrial manufacturing and consumer healthcare needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Danashmand.